Copley Scientific has announced the appointments of Jamie Clayton as Managing Director and Matthew Fenn as Head of Business Development. Clayton joined powder characterization specialist Freeman Technology in 2008 and then served as Freeman’s Operations Director beginning in 2011. Fenn has extensive experience in inhaled drug delivery and was most recently Senior Business Unit Manager at Jabil after having served in various positions at 3M, Rexam, and Nypro.
The company said that the appointments “reflect ambitious plans for the future” and that, “A primary focus will be ongoing growth of the team and embedding the company culture, to ensure optimal practice and an exceptional customer experience as expansion continues.”
Over the past few months, Copley has launched several new products, including its Volume and Resistance Compensator (VRC), which is designed to make abbreviated impactor measurements more comparable to full resolution impactor measurements, and an environmental control chamber that is meant to reduce variability in OINDP testing.
Copley Scientific CEO Mark Copley commented, “Copley has grown substantially over the last five years, and we continue to welcome new recruits at all levels to augment our well-established team. Securing senior talent is an essential element of our long-term strategy but relies on identifying experienced individuals that combine a ‘Copley’ mindset with complementary and relevant experience. Both Jamie and Matthew are an ideal fit and I’m excited to begin working with them.”
Copley added, “Jamie has a proven track record of company management, a customer-centric approach and in-depth technical expertise in all aspects of powder technology, from dry powder inhaler formulation to tablet manufacture. His appointment is a major boost for Copley that will release me to explore and progress new investment opportunities and strategic partnerships, a vital element of our ongoing plans.”
“Matthew’s key objective is to build the business development team and customer relationships that we need to drive growth. The aim is to get closer to our customers to understand exactly what they need to succeed and how best to deliver it. Copley is growing by remaining true to our core enduring values and at the same time open to new thinking. Both Jamie and Matthew can be sure of the warmest of welcomes and an exciting time ahead,” Copley said.
Read the Copley Scientific press release.
